Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia (Q34249753)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

31 July 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia (English)

1 reference

31 July 2017

1 reference

Tomomi Tenjin

1

1 reference

31 July 2017

Seiya Miyamoto

2

1 reference

31 July 2017

Nobumi Miyake

3

1 reference

31 July 2017

Shin Ogino

4

1 reference

31 July 2017

Rei Kitajima

5

1 reference

31 July 2017

Kazuaki Ojima

6

1 reference

31 July 2017

Jun Arai

7

1 reference

31 July 2017

Haruki Teramoto

8

1 reference

31 July 2017

Sachiko Tsukahara

9

1 reference

31 July 2017

Yukie Ito

10

1 reference

31 July 2017

Masanori Tadokoro

11

1 reference

31 July 2017

Kiriko Anai

12

1 reference

31 July 2017

Yasuyuki Funamoto

13

1 reference

31 July 2017

Yasuhiro Kaneda

14

1 reference

31 July 2017

Tomiki Sumiyoshi

15

1 reference

31 July 2017

Noboru Yamaguchi

16

1 reference

31 July 2017

1 January 2012

1 reference

31 July 2017

Human Psychopharmacology

1 reference

31 July 2017

27

1 reference

31 July 2017

1

1 reference

31 July 2017

90-100

1 reference

Negative features, retrieval processes and verbal fluency in schizophrenia.

31 July 2017

1 reference

Cognitive effects of six months of treatment with quetiapine in antipsychotic-naïve first-episode schizophrenia.

21 January 2018

1 reference

Neural systems engaged by planning: a PET study of the Tower of London task

21 January 2018

1 reference

Letter and category fluency in schizophrenic patients: a meta-analysis

21 January 2018

1 reference

Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature

21 January 2018

1 reference

Another view of therapy for cognition in schizophrenia.

21 January 2018

1 reference

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison

21 January 2018

1 reference

Mapping the network for planning: a correlational PET activation study with the Tower of London task.

21 January 2018

1 reference

Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).

21 January 2018

1 reference

Blonanserin: a review of its use in the management of schizophrenia

21 January 2018

1 reference

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

21 January 2018

1 reference

Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies

21 January 2018

1 reference

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

21 January 2018

1 reference

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

21 January 2018

1 reference

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

Effect of second-generation antipsychotics on cognition: current issues and future challenges

21 January 2018

1 reference

A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia

21 January 2018

1 reference

Verbal fluency and psychiatric symptoms in geriatric schizophrenia.

21 January 2018

1 reference

Schizophrenia Quality of Life Scale: validation of the Japanese version.

21 January 2018

1 reference

Brief assessment of cognition in schizophrenia: validation of the Japanese version.

21 January 2018

1 reference

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

21 January 2018

1 reference

Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

21 January 2018

1 reference

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

21 January 2018

1 reference

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

21 January 2018

1 reference

Prefrontal activation during verbal fluency tests in schizophrenia--a near-infrared spectroscopy (NIRS) study

21 January 2018

1 reference

First-episode schizophrenia: I. Early course parameters

21 January 2018

1 reference

Schizophrenic syndromes and frontal lobe performance.

21 January 2018

1 reference

Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis.

21 January 2018

1 reference

Cognitive functioning related to quality of life in schizophrenia.

21 January 2018

1 reference

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison

21 January 2018

1 reference

Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment

21 January 2018

1 reference

Neurocognition in first-episode schizophrenia: a meta-analytic review

21 January 2018

1 reference

A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book

21 January 2018

1 reference

Neural correlates of planning ability: frontal lobe activation during the Tower of London test

21 January 2018

1 reference

Planning and Spatial Working Memory: a Positron Emission Tomography Study in Humans

21 January 2018

1 reference

Antipsychotic drugs for first-episode schizophrenia: a comparative review

21 January 2018

1 reference

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

21 January 2018

1 reference

Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics

21 January 2018

1 reference

Relationship of psychopathological symptoms and cognitive function to subjective quality of life in patients with chronic schizophrenia

21 January 2018

1 reference

Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia.

21 January 2018

1 reference

Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies

21 January 2018

1 reference

Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.

21 January 2018

1 reference

Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial

21 January 2018

1 reference

What are the functional consequences of neurocognitive deficits in schizophrenia?

21 January 2018

1 reference

Neuropsychological impairments predict the clinical course in schizophrenia

21 January 2018

1 reference

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

21 January 2018

1 reference

7 January 2021

Early intervention in psychosis

1 reference

7 January 2021

Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients

1 reference

7 January 2021

Cognitive deficits in schizophrenia.

1 reference

7 January 2021

A comparison of rCBF patterns during letter and semantic fluency

1 reference

7 January 2021

Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis

1 reference

7 January 2021

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

7 January 2021

Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia

1 reference

7 January 2021

Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex

1 reference

7 January 2021

Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.

1 reference

7 January 2021

Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment

1 reference

7 January 2021

Self-report quality of life measure for people with schizophrenia: the SQLS

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1276

1 reference

31 July 2017

1 reference